News

Seed-Financing round for contextflow

Arsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin Antibodies

Valneva Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya

Arsanis Reports Financial Results and Highlights for Fourth Quarter and Full Year 2017

CEPI Partners with Themis Bioscience to Advance Vaccines Against Lassa Fever and MERS

AFFiRiS Announces Results of a Phase I Clinical Study Using AFFITOPEs® PD01A and PD03A, Confirming Safety and Tolerability for Both Compounds as well as Immunogenicity for PD01A in Early MSA patients

Themis Establishes Scientific Advisory Board of Experts in Virology and Vaccine Development

Vitamin A in cattle fodder is potentially protecting against cow´s milk allergy

MR imaging clarifies ambiguous mammography results

Boehringer Ingelheim Office Hours in Vienna on April 19, 2018

TAmiRNA & Vivomicx announce the introduction of new technology to make preclinical drug discovery and drug development more efficient.

Tailor-made cancer treatment: new drugs, new treatment strategies

Optimising healthcare provision in Europe: MedUni Vienna to coordinate EU research programme PECUNIA

APEIRON and Evotec Achieve First Milestond in Immunooncology Alliance With Sanofi

New insights could lead to lasting improvement of stem cell therapy in horses

FDA Grants Orphan Drug Designation to Zytoprotec´s Novel Dialysis Drug

Apeiron Announces Publication of Clinical Data with Anti-GD2 Antibody Demonstrating Efficacy in Relapsed & Refractory High-Risk Neuroblastoma

How a virus becomes chronic

IMBA – The Year Review: 2017 saw Awards, Leading Publications, and New Biotech Products

Bionic reconstruction – restoration at the pychologicall interface